Brief: Conduit Pharmaceuticals Announces New Addition To Its Autoimmune Pipeline
Nov 4 (Reuters) - Conduit Pharmaceuticals Inc CDT.O :
* CONDUIT PHARMACEUTICALS ANNOUNCES NEW ADDITION TO ITS
AUTOIMMUNE
PIPELINE
* CONDUIT PHARMACEUTICALS - PATENT APPLICATIONS INCLUDE
NOVEL
COMPOSITION OF MATTER FILING FOR CDT1656
Source text: ID:nGNX6mzRyD
Further company coverage: CDT.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on CDT Equity
See all newsNASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: CDT Equity - Enters Securities Purchase Agreement With Sarborg Investors On July 30, 2026 - SEC Filing
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM